Destination XL Group Inc
Change company Symbol lookup
Select an option...
DXLG Destination XL Group Inc
CENQ Cenaq Energy Corp
SJIJ South Jersey Industries Inc
CVS CVS Health Corp
HRTG Heritage Insurance Holdings Inc
ESUS ETRACS 2x Leveraged MSCI USA ESG Focus TR ETN
BSRR Sierra Bancorp
CO Global Cord Blood Corp
AHT-G Ashford Hospitality Trust Inc
LUVU Luvu Brands Inc
Go

Consumer Discretionary : Specialty Retail | Small Cap Blend
Company profile

Destination XL Group, Inc. is a specialty retailer of big and tall men's clothing with retail, wholesale and direct operations in the United States and Toronto, Canada. The Company operates under the trade names of Destination XL, DXL, DXL outlets, Casual Male XL and Casual Male XL outlets. It operates approximately 219 Destination XL stores, 16 DXL outlet stores, 32 Casual Male XL retail stores, 19 Casual Male XL outlet stores and a digital business, including an e-commerce site at dxl.com, a mobile site m.destinationXL.com and mobile application. The Company's segments include retail segment and wholesale business segment. Its retail segment operates store segment, which includes DXL Men’s Apparel stores, Casual Male XL retail stores, DXL outlet, and Casual Male XL outlet stores; and direct business segment, which includes online business, through its Website, application and third-party marketplace.

Closing Price
$5.42
Day's Change
-0.01 (-0.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.51
Day's Low
5.11
Volume
(Heavy Day)
Volume:
2,670,631

10-day average volume:
881,117
2,670,631

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APYX, APPS and ENOB

11:02 am ET August 4, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / August 4, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Apyx Medical Corporation (NASDAQ:APYX)

Class Period: May 12, 2021 - March 11, 2022

Lead Plaintiff Deadline: August 5, 2022

The complaint alleges that throughout the class period Apyx Medical Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in APYX: https://www.kleinstocklaw.com/pslra-1/apyx-medical-corporation-loss-submission-form-2?id=30575&from=1

Digital Turbine, Inc. (NASDAQ:APPS)

Class Period: February 26, 2021 - May 31, 2022

Lead Plaintiff Deadline: August 5, 2022

The APPS lawsuit alleges that throughout the class period, Digital Turbine, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's recent acquisitions, AdColony and Fyber, act as agents in certain of their respective product lines; (2) as a result, revenues for those product lines must be reported net of license fees and revenue share, rather than on a gross basis; (3) the Company's internal control over financial reporting as to revenue recognition was deficient; and (4) as a result of the foregoing, the Company's net revenues was overstated throughout fiscal 2022; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in APPS: https://www.kleinstocklaw.com/pslra-1/digital-turbine-inc-loss-submission-form?id=30575&from=1

Enochian BioSciences, Inc. (NASDAQ:ENOB)

Class Period: January 17, 2018 - June 27, 2022

Lead Plaintiff Deadline: September 26, 2022

The complaint alleges Enochian BioSciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's co-founder and inventor Serhat Gumrukcu was engaged in a variety of frauds; (2) Gumrukcu was not a licensed doctor anywhere in the world; (4) as a result of the foregoing, Gumrukcu's purported contributions to the Company lacked a reasonable basis; (5) as a result of the foregoing, the Company had overstated its commercial prospects; (6) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (7) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in ENOB: https://www.kleinstocklaw.com/pslra-1/enochian-biosciences-inc-loss-submission-form?id=30575&from=1

The Klein Law Firm, Thursday, August 4, 2022, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

SOURCE : The Klein Law Firm





View source version on accesswire.com:

https://www.accesswire.com/710865/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-APYX-APPS-and-ENOB



comtex tracking

COMTEX_411588372/2457/2022-08-04T11:02:28

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.